Literature DB >> 29578092

Quercetin dose affects the fate of hepatic ischemia and reperfusion injury in rats: An experimental research.

Mustafa Ufuk Uylaş1, Adnan Şahin2, Varol Şahintürk3, İbrahim Özkan Alataş4.   

Abstract

BACKGROUND: Quercetin found in fruits and vegetables has an antioxidative effect. We aimed to investigate the protective effects of quercetin according to different doses on hepatic and ischemia-reperfusion (I/R) injury.
METHODS: Fifty mature male Sprague-Dawley rats were randomly divided into five groups (n = 10 for each). All the animal groups underwent laparotomy. Group 1 rats served as a sham-operated group. Groups 2-5 underwent 1 h hepatic ischemia and were followed by 2 h reperfusion. Group 3-5 animals received an additional intraperitoneal dose of 25, 50 or 100 mg/kg quercetin respectively before I/R operation. Blood samples were collected for determining serum aspartate transaminase (AST), alanine transaminase (ALT) and malondialdehyde (MDA) levels. Also, liver tissue samples were taken for measuring of liver MDA concentration and for histopathology assessment.
RESULTS: The highest levels of biochemical parameters were observed in group 2. In quercetin-treated groups, serum AST, ALT, MDA levels, and tissue MDA concentration were decreased as inversely with increasing quercetin dose. Microscopic evaluation revealed that most conspicuous histological improvement was observed in 50 mg/kg quercetin co-treated rats. 25 and 100 mg/kg quercetin co-treatment could not protect completely against hepatic I/R injury.
CONCLUSION: Quercetin can be effective in preventing of hepatic I/R injury when the correct dose was used.
Copyright © 2018. Published by Elsevier Ltd.

Entities:  

Keywords:  Ischemia; Liver; Quercetin; Reperfusion

Mesh:

Substances:

Year:  2018        PMID: 29578092     DOI: 10.1016/j.ijsu.2018.03.043

Source DB:  PubMed          Journal:  Int J Surg        ISSN: 1743-9159            Impact factor:   6.071


  5 in total

Review 1.  Use of natural anti-oxidants in experimental animal models of hepatic ischemia-reperfusion injury.

Authors:  Georgios Kyriakopoulos; Georgia Valsami; Christos Tsalikidis; Michail Pitiakoudis; Alexandra K Tsaroucha
Journal:  Ann Med Surg (Lond)       Date:  2020-11-26

2.  Vildagliptin Attenuates Hepatic Ischemia/Reperfusion Injury via the TLR4/NF-κB Signaling Pathway.

Authors:  Iman O Sherif; Nora H Al-Shaalan
Journal:  Oxid Med Cell Longev       Date:  2018-10-14       Impact factor: 6.543

3.  Effect of quercetin on oxidative stress and liver function in beta-thalassemia major patients receiving desferrioxamine: A double-blind randomized clinical trial.

Authors:  Zohreh Sajadi Hezaveh; Azita Azarkeivan; Leila Janani; Farzad Shidfar
Journal:  J Res Med Sci       Date:  2019-10-25       Impact factor: 1.852

4.  The effect of Liv-52 on liver ischemia reperfusion damage in rats.

Authors:  Orhan Cimen; Hüseyin Eken; Ferda Keskin Cimen; Arif Burak Cekic; Nezahat Kurt; Asli Ozbek Bilgin; Bahadir Suleyman; Halis Suleyman; Renad Mammadov; Kamil Pehlivanoglu; Eray Kurnaz
Journal:  BMC Pharmacol Toxicol       Date:  2020-01-03       Impact factor: 2.483

5.  Quercetin Liposomal Nanoformulation for Ischemia and Reperfusion Injury Treatment.

Authors:  Margarida Ferreira-Silva; Catarina Faria-Silva; Manuela C Carvalheiro; Sandra Simões; H Susana Marinho; Paulo Marcelino; Maria Celeste Campos; Josbert M Metselaar; Eduarda Fernandes; Pedro V Baptista; Alexandra R Fernandes; Maria Luísa Corvo
Journal:  Pharmaceutics       Date:  2022-01-03       Impact factor: 6.321

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.